Oren Gilad serves as Executive at Aprea Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Oren Gilad has executed 5 insider transactions totaling $14.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 28, 2024 involved receiving (via award) 6,725 shares valued at $0.
Oren Gilad currently holds 331,495 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Oren Gilad has been a net buyer of APRE stock. They have purchased $14.6K and sold $0 worth of shares.
Oren Gilad's most recent insider trade was on Mar 28, 2024, when they sold 6,725 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.29 |
| Discretionary |
| Mar 9, 2023 | APRE | $0 | Award | 4,000 | $N/A | Discretionary |
| Aug 23, 2022 | APRE | $0 | Conversion | 6,045,100 | $N/A | Discretionary |
| Jul 28, 2022 | APRE | $0 | Award | 101,300 | $N/A | Discretionary |